Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never ...

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by ...

Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

Threat actors continue to refine their strategies, and the financial incentives for cybercrime persist. However, the combination of stronger defenses, regulatory pressure, and industry collaboration ...

From AI to value-based care, three VCs shared their controversial takes on healthcare during a recent panel discussion at the MedCity INVEST conference.

Hospitals are finding it harder than ever to collect payment for the care they provide, which is one of the many factors causing widespread financial strain among the nation’s providers.

Healthcare costs are a top concern across the United States, with 2025 anticipated to be the most expensive year for employer-sponsored insurance yet. Employers are expected to face an 8 to 9% ...

GSK is expanding its prospects in hepatology, paying $1.2 billion to acquire a drug that goes after a clinically validated liver target but with a dosing advantage that could give it a competitive ...

WeightWatchers has long been a household name, boosted by celebrity endorsements from Oprah Winfrey and Jennifer Hudson. Jean Nidetch founded the New York City company in her apartment in the ...

Digital transformation within healthcare, especially the life sciences sector, is alive and well and currently driven by the ongoing expansion of artificial intelligence, inclusive of generative ...